221 related articles for article (PubMed ID: 6818811)
1. [Clinical effects of FEIBA on hemophilia patients with inhibitors to factor VIII or IX].
Iizuka A; Kuwashima M; Nagao T
Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):987-92. PubMed ID: 6818811
[No Abstract] [Full Text] [Related]
2. Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor.
Fukui H; Fujimura Y; Takahashi Y; Mikami S; Yoshioka A
Thromb Res; 1981 Apr 1-15; 22(1-2):177-84. PubMed ID: 6794176
[No Abstract] [Full Text] [Related]
3. A comparison between a serum fraction and FEIBA fraction in haemophilia.
Hutton RA; Dormandy K; Nour-Eldin F
New Istanbul Contrib Clin Sci; 1980; 13(1):9-22. PubMed ID: 6774316
[No Abstract] [Full Text] [Related]
4. The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia A patient with inhibitor.
Tourbaf KD; Dunlap BE; Ambrus JL; Rodman DJ; Atwal AJ
J Med; 1982; 13(5-6):399-410. PubMed ID: 6820380
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hemophilia complicated by inhibitors.
Scand J Haematol Suppl; 1980; 35():135-64. PubMed ID: 6770458
[No Abstract] [Full Text] [Related]
6. Conjectures on factor VIII bypassing activity.
Aronson DL
Prog Clin Biol Res; 1981; 72():103-21. PubMed ID: 6977778
[No Abstract] [Full Text] [Related]
7. [The problem of factor VIII inhibitors in patients with congenital coagulopathies].
Klare M
Z Gesamte Inn Med; 1983 Jan; 38(2):47-50. PubMed ID: 6407220
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of immuninhibitor hemophilia A with FEIBA plasma fraction].
István L; Bariska I; Marton E
Orv Hetil; 1980 Dec; 121(51):3131-5. PubMed ID: 6784062
[No Abstract] [Full Text] [Related]
9. Maintenance of treatment logs by haemophilia patients.
du Treil S; Rice J; Leissinger CA
Haemophilia; 2010 May; 16(3):545-7. PubMed ID: 20050930
[No Abstract] [Full Text] [Related]
10. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
Mahasandana C; Patharathienskul D; Suvatte V
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
[TBL] [Abstract][Full Text] [Related]
11. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.
Sjamsoedin LJ; Heijnen L; Mauser-Bunschoten EP; van Geijlswijk JL; van Houwelingen H; van Asten P; Sixma JJ
N Engl J Med; 1981 Sep; 305(13):717-21. PubMed ID: 6790990
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the treatment of patients with factor IX deficiency to that of those with factor VIII deficiency: results of an International Survey conducted as part of the International FIX Treatment Network.
Berntorp E; Shapiro AD; Waters J; Astermark J
Haemophilia; 2014 Sep; 20(5):e362-4. PubMed ID: 25156443
[No Abstract] [Full Text] [Related]
13. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
[TBL] [Abstract][Full Text] [Related]
14. Failure of activated prothrombin complex concentrates in a hemophiliac with an anti-factor VIII antibody.
Blatt PM; White GC; McMillan CW; Webster WP
JAMA; 1984 Jan; 251(1):67. PubMed ID: 6418898
[No Abstract] [Full Text] [Related]
15. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
[TBL] [Abstract][Full Text] [Related]
16. Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIII.
Kantrowitz JL; Lee ML; McClure DA; Kingdon HS; Thomas WR
Clin Ther; 1987; 9(4):405-19. PubMed ID: 3111706
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitors and "bypass" therapy in hemophilia].
Fukutake K; Fukutake K
Nihon Rinsho; 1981; 39(12):3688-99. PubMed ID: 6803034
[No Abstract] [Full Text] [Related]
18. Effects of low-dose 'factor VIII inhibitor bypassing activity (FEIBA)' in resistant haemophilia.
Zwahlen H; Beck EA
Acta Haematol; 1980; 64(1):12-7. PubMed ID: 6774572
[TBL] [Abstract][Full Text] [Related]
19. Use of FEIBA and Amicar in the operating room--dental treatment of a patient with hemophilia and high titer factor VIII inhibitors.
Sharp HK; McIlveen LP; Schuman NJ
Spec Care Dentist; 1986; 6(5):210-2. PubMed ID: 2945270
[No Abstract] [Full Text] [Related]
20. Activated prothrombin concentrate for patients with factor VIII inhibitors.
Kurczynski EM; Penner JA
N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
